These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 2413309

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of carbocromene on ventricular fibrillation during acute myocardial ischemia in anesthetized dogs.
    Fiedler VB, Schneider S, Nitz RE.
    Pharmacology; 1982; 25(2):96-101. PubMed ID: 7134263
    [Abstract] [Full Text] [Related]

  • 4. Effects of oral carbocromene pretreatment on infarct size following experimental coronary artery occlusion.
    Fiedler VB, Nitz RE, Buchheim S.
    J Cardiovasc Pharmacol; 1982; 4(1):14-25. PubMed ID: 6176790
    [Abstract] [Full Text] [Related]

  • 5. Reduction of occlusive coronary artery thrombosis and myocardial ischemia by molsidomine in anesthetized dogs.
    Fiedler VB.
    Can J Physiol Pharmacol; 1982 Aug; 60(8):1104-11. PubMed ID: 6897011
    [Abstract] [Full Text] [Related]

  • 6. The activity of molsidomine in experimental models of ischemic cardiac disease.
    Nitz RE, Martorana PA.
    Am Heart J; 1985 Mar; 109(3 Pt 2):631-6. PubMed ID: 3919549
    [Abstract] [Full Text] [Related]

  • 7. Effects of intravenous carbocromene on infarct size following acute coronary artery occlusion and reperfusion in the dog.
    Fiedler VB, Kettenbach B, Nitz RE.
    Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):292-308. PubMed ID: 7406585
    [Abstract] [Full Text] [Related]

  • 8. Effect of molsidomine on spontaneous ventricular fibrillation following myocardial ischemia and reperfusion in the dog.
    Martorana PA, Mogilev AM, Kettenbach B, Nitz RE.
    Adv Myocardiol; 1983 Apr; 4():605-13. PubMed ID: 6687949
    [Abstract] [Full Text] [Related]

  • 9. Anti-ischemic effects of molsidomine in an experimental model of coronary artery stenosis.
    Nitz RE, Mogilev AM, Göbel H.
    Adv Myocardiol; 1983 Apr; 4():595-604. PubMed ID: 6687948
    [Abstract] [Full Text] [Related]

  • 10. Normothermic ischemic cardiac arrest and reperfusion of the isolated working rat heart: effect of carbocromene pretreatment on functional and metabolic recovery.
    Bernier M, de Leiris J.
    J Mol Cell Cardiol; 1986 Oct; 18 Suppl 4():93-7. PubMed ID: 3783745
    [Abstract] [Full Text] [Related]

  • 11. Effects of catecholamines on cardiovascular actions of molsidomine in anesthetized dogs.
    Fiedler VB, Göbel H, Nitz RE.
    J Cardiovasc Pharmacol; 1983 Oct; 5(3):491-8. PubMed ID: 6191151
    [Abstract] [Full Text] [Related]

  • 12. Effects of dihydroergotamine on hemodynamic molsidomine actions in anesthetized dogs.
    Fiedler VB, Göbel H, Nitz RE.
    Can J Physiol Pharmacol; 1984 Jun; 62(6):634-9. PubMed ID: 6547632
    [Abstract] [Full Text] [Related]

  • 13. Molsidomine on cardiovascular leukotriene D4 actions.
    Fiedler VB, Abram TS.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):152-7. PubMed ID: 3839292
    [Abstract] [Full Text] [Related]

  • 14. Prevention with molsidomine of coronary artery spasm caused by alkalosis.
    Weber S, Kahan A, Pailleret JJ, Guérin F, Degeorges M.
    Am Heart J; 1985 Mar; 109(3 Pt 2):704-7. PubMed ID: 3838408
    [Abstract] [Full Text] [Related]

  • 15. Effect of vasodilator drugs on coronary occlusion and reperfusion arrhythmias in anesthetized dogs.
    Elfellah MS, Ogilvie RI.
    J Cardiovasc Pharmacol; 1985 Mar; 7(5):826-32. PubMed ID: 2413288
    [Abstract] [Full Text] [Related]

  • 16. The effect of molsidomine on intramyocardial pressure and regional myocardial blood flow in the canine ischemic myocardium.
    Kinoshita M, Mashiro I, Mitsunami K, Fukuhara T, Motomura M, Bito K, Kawakita S.
    Jpn Circ J; 1985 May; 49(5):507-15. PubMed ID: 3839541
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Substituted sydnonimines: hemodynamic effects and distribution of coronary blood flow in normal and ischemic myocardium].
    Mosca SM, Gelpi RJ, Cingolani HE.
    Acta Physiol Pharmacol Latinoam; 1985 May; 35(3):361-73. PubMed ID: 2938418
    [Abstract] [Full Text] [Related]

  • 19. Effects of yohimbine and desipramine on cardiac noradrenaline release and ventricular arrhythmias during acute coronary artery occlusion and reperfusion in anesthetized dogs.
    Yamaguchi N, Lamontagne D, Boudreau G, Nadeau R, de Champlain J.
    Can J Physiol Pharmacol; 1987 Nov; 65(11):2244-53. PubMed ID: 3449186
    [Abstract] [Full Text] [Related]

  • 20. The new long-acting coronary artery dilator molsidomine and its metabolite SIN-1.
    Sobolski J, Vandermoten P, Stoupel E, Berkenboom G, Degre S.
    Am Heart J; 1985 Mar; 109(3 Pt 2):700-3. PubMed ID: 3838407
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.